Details for New Drug Application (NDA): 214733
✉ Email this page to a colleague
NDA 214733 describes VENETOCLAX, which is a drug marketed by Dr Reddys and is included in one NDA. Additional details are available on the VENETOCLAX profile page.
The generic ingredient in VENETOCLAX is venetoclax. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the venetoclax profile page.
The generic ingredient in VENETOCLAX is venetoclax. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the venetoclax profile page.
Summary for 214733
| Tradename: | VENETOCLAX |
| Applicant: | Dr Reddys |
| Ingredient: | venetoclax |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | May 15, 2026 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | May 15, 2026 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | May 15, 2026 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
